Pharmaceuticals - Community Register

  

Community list of not active veterinary medicinal products


WITHDRAWN  

Product information

Invented name: Gonazon

   This product is authorized under a different brandname in the EU in the folowing languages:
   - Gonazón (ES)
Auth. number : EU/2/03/040
INN : Azagly-nafarelin
ATC: Anatomical main group: QH - Systemic hormonal preparations, excluding sex hormones and insulins
Therapeutic subgroup: QH01 - Pituitary and hypothalamic hormones and analogues
Pharmacological subgroup: QH01C - Hypothalamic hormones
Chemical subgroup: QH01CA - Gonadotropin-releasing hormones
Chemical substance: QH01CA - Gonadotropin-releasing hormones
(See WHO ATCvet Index)
Indication: Induction and synchronisation of ovulation for the production of eyed-eggs and fry
Marketing Authorisation Holder: Intervet International B.V.
Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/07/2003 Centralised - Authorisation EMEA/V/C/75 (2003)2742 of 22/07/2003
23/03/2004 Centralised - Notification EMEA/V/C/75/N/1 (2004)1047 of 19/03/2004
15/01/2007 Centralised - Variation EMEA/V/C/75/X/2 (2007)116 of 11/01/2007
05/09/2007 Centralised - Variation (no change in Commission Decision) EMEA/V/C/75/IA/3
17/06/2008 Centralised - Renewal EMEA/V/C/75/R/4 (2008)2952 of 13/06/2008
22/07/2009 Centralised - Variation (no change in Commission Decision) EMEA/V/C/75/IB/5
22/03/2012 Centralised - Withdrawal (2012)1937 of 19/03/2012